|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Investments, at fair value | ||||||||||||||||
| Non-controlled non-affiliated | ||||||||||||||||
| Non-controlled affiliated | ||||||||||||||||
| Controlled | ||||||||||||||||
| Total investments, at fair value | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||
| Interest and dividend receivable | ||||||||||||||||
| Receivable from unsettled transactions | ||||||||||||||||
| Unrealized appreciation on foreign currency forward contracts | ||||||||||||||||
| Deferred tax assets | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Debt (net of deferred financing costs of $9,527 and $5,841 respectively) | ||||||||||||||||
| Distributions payable | ||||||||||||||||
| Interest and other debt financing costs payable | ||||||||||||||||
| Management fees payable | ||||||||||||||||
| Incentive fees payable | ||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||
| Directors’ fees payable | ||||||||||||||||
| Unrealized depreciation on foreign currency forward contracts | ||||||||||||||||
| Unrealized depreciation on interest rate swaps | ||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net assets | ||||||||||||||||
| Common stock, par value $0.001 per share (200,000,000 shares authorized, 36,845,952 and 36,969,285 shares issued and outstanding, respectively) | ||||||||||||||||
| Paid-in capital in excess of par value | ||||||||||||||||
| Accumulated earnings (loss) | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and net assets | ||||||||||||||||
| Net asset value per share | ||||||||||||||||
Loading...